Skip to main content
. 2022 Dec 25;11(1):47. doi: 10.3390/biomedicines11010047

Figure 4.

Figure 4

Serum-relative intensities of TAG (18:0/18:1/20:0), PC (16:0e/26:4), and PC (18:1/22:6) in the HCs and AS groups. (A,B) The levels of TAG (18:0/18:1/20:0) and PC (16:0e/26:4) were increased in the patients with AS (p < 0.0001). (C) The levels of PC (18:1/22:6) were decreased in the patients with AS (p < 0.0001). **** p < 0.001.